Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing ESPB and SPSIPB nerve blocks for pain after VATS

Official title: Comparison of the Effects of Ultrasound-Guided Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane Block on Postoperative Analgesia Management in Patients Undergoing Video-Assisted Thoracoscopic Surgery

Run by Bursa City Hospital · NCT07232940 · Data updated 2026-11-12

This trial will test whether the serratus posterior superior intercostal plane block (SPSIPB) or the erector spinae plane block (ESPB) gives better pain relief and satisfaction for adults having VATS.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment90 (estimated)
SponsorBursa City Hospital
Government
Locations1 site (Bursa, Nilüfer)
StatusRecruiting
StartedNovember 15, 2025
Main results expectedMay 15, 2026
Study endsMay 15, 2026
Registry record updatedDecember 16, 2025
Trial IDNCT07232940 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with ASA physical status I–III scheduled for elective VATS who do not have contraindications to regional nerve blocks are ideal candidates.

Probably not a fit

Patients with coagulopathy, local infection at the injection site, known local anesthetic allergy, current chronic opioid therapy, uncontrolled systemic disease, or pregnancy are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Video-assisted thoracoscopic surgery (VATS) causes significant postoperative pain despite small incisions, and effective regional analgesia is important to reduce acute and chronic pain. Current PROSPECT guidance supports ESPB or paravertebral block for VATS, while the serratus posterior superior intercostal plane block (SPSIPB) is a recently described technique that may cover C3–T10 dermatomes. This study will compare postoperative analgesic efficacy and patient satisfaction between ESPB and SPSIPB in adult elective VATS patients treated at Bursa City Hospital. Typical inclusion criteria are adults 18–65 years with ASA I–III, with exclusions for coagulopathy, local anesthetic allergy, chronic opioid use, uncontrolled major comorbidities, infection at the injection site, and pregnancy or breastfeeding.

Why it matters

Potential benefit: If one block provides better and longer pain relief with fewer opioid needs, patients could experience less acute pain, lower opioid use, and potentially lower risk of chronic postoperative pain after VATS.

How similar studies have gone: ESPB and paravertebral blocks have prior supportive data for VATS analgesia, whereas SPSIPB is a newly described technique with limited comparative evidence to date.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18-65 years with ASA physical status I-III who will undergo elective video-assisted thoracoscopic surgery (VATS) will be included.

Exclusion Criteria:

* Patients who do not consent to participate in the study

Patients with coagulopathy

Patients with a history of local anesthetic allergy or toxicity

Patients with hepatic or renal failure

Patients with uncontrolled diabetes

Patients with uncontrolled hypertension

Mentally disabled patients

Patients receiving chronic pain treatment (opioid users)

Patients using antidepressant medication

Patients with neuropathic pain

Mentally disabled patients

Presence of infection at the injection site

Pregnant or breastfeeding women, or those with suspected pregnancy

Where it's running

  • Bursa City Hospital
    Bursa, Nilüfer, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.